Franzosini SA has obtained the GDP – Good Distribution Practice for Medicinal Products certification, issued by SQS – Swiss Association for Quality and Management Systems, thus adding a new and important element to its quality management system. This is a significant milestone that confirms the company's compliance with the European guidelines 2013/C 343/01 for the safe distribution of medicinal products for human use.
Obtaining the GDP certification represents a strategic milestone that strengthens Franzosini's position in the pharmaceutical logistics and sensitive goods distribution sector, confirming its status as a qualified partner for companies in the pharma & healthcare world.
The certification process required an in-depth review of operational procedures, with particular attention to the transport and storage phases of medicinal products. Franzosini has introduced and consolidated specific protocols in the areas of: environmental controls; cold chain monitoring; staff training; supplier qualification; complete traceability of logistics flows.
The company has equipped itself with environmental monitoring instruments in warehouses and on transport vehicles, to ensure that every shipment is carried out in compliance with the conditions required for the preservation of medicinal products. The traceability of logistics flows, from collection to final delivery, is guaranteed by dedicated IT systems capable of documenting every step.